the UK Extension to the EU-U.S. DPF, and the Swiss-U.S. Data Privacy Framework (Swiss-U.S. DPF) as set forth by the U.S. Department of Commerce. ICON has certified to the U.S. Department of Commerce that it adheres to the EU-U.S. Data Privacy Framework Principles (EU-U.S....
Legal Footer © 2024 ICON plc Disclaimer Privacy & Data Cookies 我们使用 Cookie 以允许我们网站的正常工作、个性化设计内容和广告、提供社交媒体功能并分析流量。我们还同社交媒体、广告和分析合作伙伴分享有关您使用我们网站的信息。 接受所有 Cookie Cookie 设置 ...
View: Download DOC Download PDF Download XLS Download XBRL
ICON Corporate Finance, a specialist in Technology M&A, has advised Hub Network Services Ltd (‘HNS’), a B2B, managed services provider, on its sale to SysGroup Plc. Based in Bristol, UK, HNS is a managed connectivity and co-location solutions provider with a customer base which includes ...
iconplc.com Are you an investor? Submit your portfolio details now to be considered in our investor rankings.Submit portfolio details Investments1 Partners & Customers10 Service Providers1 About ICON ICON (NASDAQ: ICLR) specializes in drug development for the pharmaceutical, biotechnology and medical ...
ICON plc, a global provider of drug and device development and commercialization services to pharmaceutical, biotechnology, medical device industries, announced that it has acquired a majority shareholding in MeDiNova Research, a site network with research sites in key markets in Europe and Africa, and...
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced details of its new translational medicine unit in Manchester, UK. The unit is the first deliverable from a collaborative agreement between ICON and the ...
ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us on our mission to shape the future of clinical development. ...
President and CEO, MedPass International, an ICON plc company Sarah has more than 30 years' experience of medical device regulation and clinical trials with an emphasis on emerging technologies. She is founder and President of MedPass International, the leading European CRO and consultancy for the...